郭昊天 / Guo Haotian

Overview

郭昊天 / Guo Haotian enters the wiki as the returning 无时差研究所 guest who discusses GLP-1 weight-loss drugs from personal-use, biotech, and public medical-literacy angles.

Current Profile

In the EP384 source, Guo functions as an industry-adjacent explainer rather than as a clinician. He uses his own tirzepatide experience, mechanism explanations, drug-development logic, and market observations to separate regulated metabolic medicine from casual appearance optimization. His strongest contribution is boundary-setting: GLP-1 drugs can be effective for selected people, but personal response, side effects, pregnancy uncertainty, rebound, muscle loss, and unverified peptide injection all need caution.

Key Characteristics

• Returning podcast guest associated in the episode with earlier synthetic-biology discussion.
• Personal-use narrator whose tirzepatide response differed from the expected appetite-suppression pattern.
• Mechanism explainer connecting GLP-1, GIP, insulin, gastric emptying, satiety, and energy expenditure.
• Biotech-industry interpreter linking patents, approvals, production capacity, pricing, and multi-target drug development.
• Cautionary voice against unverified self-injection and research-use peptides.

Evidence

• Guest role - EP384-普通人也能打得起的“司美格鲁肽”，减肥针“一针瘦十斤”背后的真相与代 introduces Guo as a returning guest who had previously discussed synthetic biology and is currently using an injectable weight-loss drug.
• Personal-use case - EP384-普通人也能打得起的“司美格鲁肽”，减肥针“一针瘦十斤”背后的真相与代 records his atypical report that tirzepatide made him hungrier while his weight still fell, alongside dehydration and headaches.
• Mechanism explanation - EP384-普通人也能打得起的“司美格鲁肽”，减肥针“一针瘦十斤”背后的真相与代 has him distinguish semaglutide’s GLP-1 focus from tirzepatide’s GLP-1/GIP dual-target profile.
• Industry interpretation - EP384-普通人也能打得起的“司美格鲁肽”，减肥针“一针瘦十斤”背后的真相与代 links price changes, patent expiration, production capacity, Chinese GLP-1 development, and multi-target drugs to market competition.
• Safety boundary - EP384-普通人也能打得起的“司美格鲁肽”，减肥针“一针瘦十斤”背后的真相与代 has him advise against injecting compounds that have not passed clinical validation.

Qualifications

This page is source-scoped to Guo’s EP384 role. The source does not establish his full biography, institutional affiliation, clinical credentials, or complete work history, and his personal drug response should not be generalized as typical.

What Changed

• Created Guo Haotian as the guest entity for EP384.
• Captured his role as a biotech-and-personal-experience explainer of GLP-1 medicine boundaries.

Relationships

• 无时差研究所 - show where he appears as guest.
• GLP-1 Agonists - main drug category he explains.
• Lifestyle Weight Management / 生活方式体重管理 - maintenance frame he keeps tied to drug use.
• Muscle As Longevity Infrastructure - muscle-preservation risk he discusses during weight loss.
• Gray-Market Peptides - unverified self-injection boundary he cautions against.
• Tech-Culture Biohacking - adjacent optimization culture visible in research-use peptide examples.